Friday, November 05, 2021 – 06:45am
PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models
This forum focuses on the interdisciplinary and cutting-edge technologies...
The 3rd CMC-China 2021
Time: September 29-30, 2021
Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China.
Synergy of Centralized China’s Drug Volume-ba...
The “Summit on COVID-19 Diagnostics & Treatment”
September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing.
The outbreak of Corona Virus Disease 2019 (...
6 October 2021
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to
Benjamin List
Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany
Da...
Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid.
Share Article
On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...